#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Internal Medicine - Issue 2/2022

Editorial

79

Main Topic

82

Hana Rosolová

85

ADA Standards of Medical Care in Diabetes 2022 – what’s new?

Jan Škrha jr.

89

Oral semaglutide – Rybelsus®, the first GLP-1 receptor agonist for oral use in clinical practice

David Karásek

96

The position of SGLT2 inhibitors in current medical practice – update 2022

Martin Prázný

Review Articles

104

What do the new ESC Guidelines for the treatment of heart failure bring to internists?

Jindřich Špinar, Lenka Špinarová, Jiří Vítovec

111

Anticoagulation in cancer patients; new recommendations based on randomized clinical trials

Dalibor Musil

116

Colorectal cancer in patients with diabetes – epidemiology, pathophysiology and applications for clinical practice

Alexandra Romanová, Jana Malinovská, Michala Lustigová, Jana Urbanová, Ludmila Brunerová, Veronika Vejtasová, Ankita Verma, Tung A. Duong, Jan Šťovíček, Jan Brož

In Brief

124

Any expectations from the more powerful dulaglutide?

Jan Škrha jr.

127

Pituitary incidentaloma

Michal Kršek

131

Pharmacological possibilities of vitamin C in oncology

Marek Lapka

Internal Medicine

Issue 2

2022 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#